Patients with breast cancer-related bone metastasis exhibit increased serum levels and mRNA expression of IL-11, suggesting that IL-11 is involved in bone metastasis via STAT3 phosphorylation [74]. The gene discussed is IL11; the disease is breast carcinoma.